SUMMARY The uptake of ovalbumin (OA) from egg and beta-lactoglobulin (BLG) from cow's milk into the blood was investigated for seven hours after a test meal in five children with coeliac disease on a gluten free diet and after gluten challenge, and in five children with normal jejunal mucosa. Ovalbumin was detectable by ELISA in three of five coeliac children (maximal concentrations 8-178 ng/ml serum) and in five of five controls (maximal 4-91 ng/ml serum). Betalactoglobulin was detected in three of five coeliac children (maximal 0-6-6 ng/ml serum) and in two of five controls (maximal 0-5 and 50 ng/ml serum). No clear relationship was seen between maximal antigen concentrations and titres of serum IgG or IgA antibodies determined by ELISA, or as percentage antigen binding in a Farr type radioimmunoassay. Ovalbumin and beta-lactoglobulin was seen in serum of all coeliac patients and controls by HPLC fractionation in combination with ELISA, either in high MW fractions, or at the M, of native OA and BLG, respectively. In one control degradation products (about 17 kD) of BLG were detectable in serum. The serum concentrations of OA and BLG were increased on gluten challenge in four of five coeliac children, indicating increased macromolecular passage through the gut mucosa in untreated coeliac disease.
decreased amounts as compared with healthy subjects. " 6 No clear evidence for altered gut permeability for proteins was obtained when the uptake of protein antigen was investigated in six coeliac children. 7 To further address the question of macromolecular passage across the gut mucosa in patients with coeliac disease we have studied the uptake of two dietary protein antigens in coeliac children on a gluten free diet and after gluten challenge. In addition, the antigen uptake was investigated in children suspected of having coeliac disease, but with the subsequent finding of normal jejunal biopsies. ELISA techniques were used for antigen determination. The absorbed proteins were analysed with regard to their size distribution by high pressure liquid gel permeation chromatography (HPLC) in combination with ELISA, and the levels of the corresponding antibodies were determined. 1062
Methods
Five children (age 21/2-13 years) were studied with a diagnosis of childhood coeliac disease, established by repetitive jejunal biopsies, as recommended by the European Society for Paediatric Gastroenterology and Nutrition." The biopsies were taken under general anaesthesia, with a Quinton pediatric capsule under radiological control at the ligament of Treitz. The procedure was carried out at initial admission, after one year or more on a gluten free diet and if the mucosa was normalised after three months of gluten challenge (minimum 10 g of gluten per day) or on the appearance of severe symptoms. The biopsy was considered completely normal in four children and in one child (no 1) the mucosa was not completely normalised after one year of gluten free diet (Table  1) . One of the coeliac patients (no 2) in addition was IgA-deficient.
A gastric tube was installed at the second and third biopsy procedure. One hour after the end of anaesthesia the child was given a test meal consisting of 2 ml raw egg and 10 ml cow's milk per kg body weight through the gastric tube. Blood samples were taken from an indwelling cannula before the test meal (t,,) and 30, 60, 120, 180, 240, and 420 minutes after the meal, during which time the patient took nothing by mouth. Serum was prepared in aliquots and stored at -60°C. The subjects had fasted for at least eight hours before instillation of the test meal.
The disease controls included five children (age 3V/2-13 years) suspected of coeliac disease and without clinical allergy to milk or egg. These children underwent a jejunal biopsy, which was found normal ( Table 2 ). The experimental procedure was the same as outlined above. The investigation was approved by the Regional Scientific Ethical Committee, and informed consent was obtained. The wells of microplates were coated with affinity purified rabbit F(ab')2 anti-OA (400 ng/ml) or F(ab')2 anti-BLG antibody (1000 ng/ml), raised and purified by us. Control wells were coated with normal rabbit F(ab')2. The wells were quenched with HSA in Tris-buffered saline (TBS) for one hour, followed by washing three times with 0-05% Tween 20 in TBS (TBS-Tween). Test sera or standards diluted 1:10 in TBS-Tween were added and incubated overnight. The wells were washed as above and incubated with biotinylated anti-OA antibody or biotinylated anti-BLG antibody overnight. Development was done with avidin beta-galactosidase for two hours, followed by o-nitrophenyl-beta-D-galactopyranoside for one hour as substrate. All samples were tested in duplicate.
Quantification was obtained by the construction of a calibration curve (0.04-270 ng/ml of OA or BLG). The detection limit of the assays was approximately 0 3 ng antigen/ml serum. Separate serum control preparations for OA-detection showed a betweenseries coefficient of variation (CV) (n=20) of 0 (22 at The CV of the Ve for the markers were below 0-02 (n=5). Microplate wells were coated with F(ab')2 anti-OA or F(ab'), anti-BLG antibody, quenched with HSA and washed three times in TBS-Tween. Twenty five microlitres of 10% Tween 20 in TBS was added to further reduce non-specific binding and fractions from the HPLC column were collected into the microplate. The fractions were analysed for OA and BLG as described above, with a serum calibration curve and control serum samples included in the lower two rows of the plate, as described for ELISA's for antigen detection.
Sera from t0 of the experiment and the samples with the maximal amounts of OA or BLG (120-420 min samples) were analysed. When no antigen was detected in the unfractionated serum samples by ELISA, the 180 minute sample was chosen for fractionation.
ANTIBODY DETERMINATIONS
A modified antigen binding (Farr type) radioimmuno-assay20 '2 was used to determine serum antibodies to OA and BLG. Serum (1:2, 1:10, 1:50) was mixed with O>1-GA or '1-BLG, and incubated at 37°C for one hour and overnight at 4°C. Polyethylene glycol 6000 (final concentration 15% in TBS-Tween) was -idded and the preparation incubated on ice for 30 minutes. After centrifugation and washing, the radioactivity of the precipitate was determined. Antibody titres were expressed as reciprocals of the serum dilution precipitating 10% of the total protein bound radioactivity (the amount precipitated in 10% cold trichloroacetic acid).
Biotin-avidin amplified ELISA was used for the determination of serum anti-OA and anti-BLG antibodies of the IgG22 and IgA class. Ovalbumin or BLG was coated onto microplates followed by blocking with HSA. Serum samples for IgG antibody determination were diluted 1:100 and 1:500, and for IgA determination 1:50, 1:100 and 1:200, and incubated in the microplate. After washings biotinylated anti-IgG or anti-IgA antibody was added. Development with avidin-beta-galactosidase was done as described for antigen determination. Levels of IgG antibodies were related to dilutions of a serum with high antibody titre and expressed in mU/ml. Titres of IgA antibodies were expressed as the highest dilutions giving a signal significantly above the background.
Results

DETERMINATION OF OVALBUMIN IN SERA
Ovalbumin was detectable in the sera of four of five coeliac patients (Fig. 1) . The amounts of OA in serum were in three of four patients clearly higher (2.6-180 ng/ml) at the time of challenge with gluten, when the jejunal mucosa showed villous atrophy, than after one year on a gluten free diet, when the jejunal mucosa was normal. In one patient (no 1), who did not have a fully normalised jejunal mucosa after the diet period (Table 1) , slightly larger amounts of OA were seen after the diet period. Ovalbumin was already detectable in the 30 minute samples in three individuals (nos 1, 2, and 5), and at 120 minutes in one case (no 3). A well defined peak of serum OA was seen only in two individuals (nos 1 and 2).
The children, who had a normal jejunal biopsy (disease controls) absorbed varying amounts of OA (0-100 ng/ml) after the test meal, within the same range of magnitude as the coeliac children (Fig. 1,  controls) . Ovalbumin reached maximal levels 120-240 minutes after the test meal.
DETERMINATION OF BETA-LACTOGLOBULIN IN SERA
Beta-lactoglobulin was observed in the sera of three of five coeliac patients (Fig. 2 ), but at lower levels than OA (less than 28 ng/ml serum). After a gluten free diet only one individual (no 5) had a detectable level of BLG. This child had measurable amounts of BLG in the to sample obtained after gluten challenge.
Peak levels of BLG were found at 60-240 minutes after the meal.
Beta-lactoglobulin was detectable in two disease controls (Fig. 2, disease controls) 
with HPLC. The amounts of OA detected in four of five of the coeliac children were clearly higher at provocation with gluten than after one year on a diet (Fig. 3) . The fifth coeliac child (no 1), however, had larger amounts of OA after the diet period.
In four of five coeliac children (nos 2, 3, 4, and 5) the anti-OA reactive material was located mainly in the high MW fractions. The high-MW OA in one patient (no 3) eluted at the VO (about 660 kD), whereas the aggregated OA in the rest of the coeliac children was of a smaller size. In contrast, in one patient (no 1) most of the OA eluted at the Ve of native OA (Fig. 3) .
Ovalbumin was observed in high MW fractions in five of five control children (Fig. 3, disease controls) , and in addition eluted at the V, of native OA in 2/5 controls. The MW of the OA aggregates was below VO, except in one case (control no 5).
In four of the five coeliac children BLG was detected by HPLC-ELISA, in larger amounts after gluten challenge than after gluten free diet (Fig. 4) . Beta-lactoglobulin was observed in the high MWfractions in all the coeliacs (nos 1-5), predominantly between VO, and the elution volume of IgG. Two patients (nos 1 and 2) with no detectable BLG in unfractionated serum had demonstrable high MW BLG after HPLC fractionation. Patient no 1, in which the gut mucosa had not completely normalised after a year of gluten free diet, had low comparable amounts of BLG after the diet period and at gluten challenge.
In the disease controls group (Fig. 4 , disease controls) BLG was demonstrated in the high MW fractions only, except for one child (disease control no 1), whose serum also contained BLG fragments.
ANTIBODY DETERMINATIONS
Antibodies were in all cases determined on fasting sera. Levels of IgG anti-OA antibodies were higher in the coeliac children than in the disease controls (Table 3) , and so were IgA anti-OA antibodies except in the IgA-deficient individual, whereas the anti-OA antibody titres as determined by the Farr type assay overlapped. The IgA and IgG anti-OA antibodies increased upon gluten challenge in the coeliac children but there was no clear relationship between the degree of OA uptake in serum and serum antibody levels. The coeliac child with IgAdeficiency (no 2), however, had a high concentration of OA in serum, and patient no 4 with no OA in serum had the highest IgG and IgA anti-OA levels in serum.
The IgA anti-BLG antibody titres tended to be higher in coeliac children than in disease controls, whereas the corresponding IgG antibodies (ELISA) and the concentration of anti-BLG antibodies as determined by a Farr type assay were similar in coeliac children and in controls ( The appearance of the antigens in serum was investigated in each coeliac child after a gluten free diet period and at gluten challenge. The antigen levels showed an increase after gluten challenge in four of five coeliac children. In the one patient with the reverse pattern of OA uptake and no differences in BLG concentrations before and after gluten challenge (no 1, Figs. 1 and 4 ) the histology of the jejunal mucosa was not completely normalised after the diet period. Thus, the uptake of OA and BLG tended to increase (in eight of 10 samples), when the mucosa exhibited villous atrophy.
The permeability of the gut to macromolecules may be increased in coeliac disease because of a greater leakiness or decreased due to a diminished absorptive area. The mucosal damage may affect both intercellular passage and intracellular transport, the latter probably being the most important under physiological circumstances. reported a diphasic uptake of BLG in the sera of adults and children, hypothesising uptake both through the lymphatic and the local venous system. Such a diphasic uptake was not observed in the present study. Furthermore, seven of nine individuals with detectable OA in serum and three of five with BLG in serum showed no clear antigen peak over a seven hour period after the meal. This suggests a slow metabolism of the antigen resembling our results in healthy adults, some of whom had detectable OA aggregates in the circulation as late as 36-48 hours after a test meal. 24 We did not in this limited study observe any clear relationship between maximum levels of BLG and OA in serum and antibody titres as measured by Farr assay or ELISA's for IgG or IgA antibodies (Tables 3  and 4) . A high uptake of the antigens, however, was observed in the individual suffering from coeliac disease combined with IgA-deficiency. Our previous study24 of healthy adults indicated a positive relationship between the presence of high-MW OA and IgG anti-OA antibody levels. The majority of the (Fig. 4 , disease controls). This observation for OA as in accordance with our findings in healthy adults.' Either the rabbit antibodies raised against the intact proteins do not recognize the epitopes on putative fragments or the fragments are rapidly degraded. Because BLGfragments were detectable in one individual, the latter explanation seems more likely.
The human gastrointestinal tract allows a certain degree of physiological absorption of undegraded macromolecular dietary antigen, free or antibody bound. This antigen uptake is influenced by the permeability of the gut and the local and systemic immune responses. The present study indicates that challenge with gluten and subsequent development of villous atrophy in coeliac children leads to increased uptake of macromolecular dietary antigens. 
